Entrada en vigor
1 de enero 2021
Code 2021 - New version will be available soon
Inicio Título III - Entrada en Vigor del Código
Home Title III. Coming into effect of the Code

Title III – COMING INTO EFFECT OF THE CODE

38. COMING INTO EFFECT AND TRANSITIONAL PROVISIONS OF THE CODE

This Code comes into effect on 27 May 2016 and revokes those that were in effect up to this date.

Notwithstanding the foregoing, the disclosure on 2017 of the Transfers of Value made during 2016, may be done in accordance with the consent rules included in the previous edition of the Code, in effect until 26 May 2016.

Transfers of Value made by pharmaceutical companies from 1 January 2017 to Healthcare Professionals shall not require the previous consent granted by said Healthcare Professionals, and will be published on each reporting period on an individual basis, except those covered in article 18.5.

In any case, for the first data publication on June 2016, of Transfers of Value made during 2015, pharmaceutical companies shall have already in place in their websites, the measures established by the report issued by the SDPA, of 22 April 2016 (Code Annex I), with the aim of avoiding further processing of this data.

Listado inicial

lisini

This Code supersedes and revokes:

The Code of Practice for the Pharmaceutical Industry (June 2014 edition).

Lisfin

ListadoFin

Título III – ENTRADA EN VIGOR DEL CÓDIGO

38. ENTRADA EN VIGOR DEL CÓDIGO

Este Código entra en vigor el día 1 de enero de 2021 y deroga los vigentes hasta esa fecha.

ListadoIni

lisini

Este Código sustituye y deroga:

Código de Buenas Prácticas de la Industria Farmacéutica (edición octubre 2016).

Lisfin

ListadoFin

These texts are the non-official translation of the Spanish version of the texts approved by Farmaindustria General Assembly. The Spanish versions shall always prevail.